BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
Latest, FY2025
287
Period ended Dec 31, 2025
Change on a year earlier
-144.5%
-645 in FY2024
History
12 years
Since FY2014
Sources
8
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net income (loss) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 287 | -144.5% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | -645 | -26.9% | Form 10-K (filed 2025-02-27) ↗ |
| FY2023 | Dec 31, 2023 | -882 | -56.0% | Form 10-K (filed 2024-02-26) ↗ |
| FY2022 | Dec 31, 2022 | -2,004 | +37.5% | Form 10-K (filed 2023-02-27) ↗ |
| FY2021 | Dec 31, 2021 | -1,458 | -10.3% | Form 10-K (filed 2023-02-27) ↗ |
| FY2020 | Dec 31, 2020 | -1,625 | +71.3% | Form 10-K (filed 2023-02-27) ↗ |
| FY2019 | Dec 31, 2019 | -949 | +40.8% | Form 10-K (filed 2020-03-02) ↗ |
| FY2018 | Dec 31, 2018 | -674 | +623.7% | Form 10-K (filed 2019-02-28) ↗ |
| FY2017 | Dec 31, 2017 | -93.1 | -21.9% | Form 10-K (filed 2018-02-28) ↗ |
| FY2016 | Dec 31, 2016 | -119 | +108.8% | Form 10-K (filed 2017-03-22) ↗ |
| FY2015 | Dec 31, 2015 | -57.1 | +212.0% | Form 10-K (filed 2017-03-22) ↗ |
| FY2014 | Dec 31, 2014 | -18.3 | – | Form 10-K (filed 2017-03-22) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Net income (loss) ($M) ($M), annual FY2014–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/fs_ni
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.